Facebook
Twitter
Telegram
Report an ErrorUrovant Sciences Ltd. Financial Statements 2011-2024 | UROV
Annual Financial Statements Urovant Sciences Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
273 B | 176 B | - | - | - | - | - | - | - | - |
Shares |
30.4 B | 23.5 B | - | - | - | - | - | - | - | - |
Net Income |
-147 M | -111 M | -37.1 M | -27 M | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - |
EBITDA |
-143 M | -111 M | -37 M | -27.1 M | - | - | - | - | - | - |
Operating Expenses |
139 M | 111 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
46.3 M | 18.6 M | 4.64 M | 1.02 M | - | - | - | - | - | - |
All numbers in USD currency